Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
ACS Appl Mater Interfaces ; 13(41): 48414-48422, 2021 Oct 20.
Artigo em Inglês | MEDLINE | ID: mdl-34633793

RESUMO

A novel supramolecular DNA hydrogel system was designed based on a directly synthesized chemically branched DNA. For the hydrogel formation, a self-dimer DNA with two sticky ends was designed as the linker to induce the gelation of B-Y. By programing the linker sequence, thermal and metal-ion responsiveness could be introduced into this hydrogel system. This supramolecular DNA hydrogel shows shear-thinning, designable responsiveness, and good biocompatibility, which will simplify the hydrogel composition and preparation process of the supramolecular DNA hydrogel and accelerate its biomedical applications.


Assuntos
DNA Complementar/química , Hidrogéis/química , Técnicas de Cultura de Células/métodos , Meios de Cultura/síntese química , Meios de Cultura/química , Meios de Cultura/toxicidade , DNA Complementar/síntese química , DNA Complementar/genética , DNA Complementar/toxicidade , Quadruplex G , Células HeLa , Humanos , Hidrogéis/síntese química , Hidrogéis/toxicidade , Hibridização de Ácido Nucleico , Transição de Fase , Reologia , Temperatura de Transição , Viscosidade
2.
Emerg Microbes Infect ; 9(1): 2714-2726, 2020 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-33295839

RESUMO

The MERS-CoV isolated during the 2015 nosocomial outbreak in Korea showed distinctive differences in mortality and transmission patterns compared to the prototype MERS-CoV EMC strain belonging to clade A. We established a BAC-based reverse genetics system for a Korean isolate of MERS-CoV KNIH002 in the clade B phylogenetically far from the EMC strain, and generated a recombinant MERS-CoV expressing red fluorescent protein. The virus rescued from the infectious clone and KNIH002 strain displayed growth attenuation compared to the EMC strain. Consecutive passages of the rescued virus rapidly generated various ORF5 variants, highlighting its genetic instability and calling for caution in the use of repeatedly passaged virus in pathogenesis studies and for evaluation of control measures against MERS-CoV. The infectious clone for the KNIH002 in contemporary epidemic clade B would be useful for better understanding of a functional link between molecular evolution and pathophysiology of MERS-CoV by comparative studies with EMC strain.


Assuntos
DNA Complementar/toxicidade , Coronavírus da Síndrome Respiratória do Oriente Médio/genética , Animais , Linhagem Celular Tumoral , Chlorocebus aethiops , Células Clonais , Cricetinae , Humanos , Coronavírus da Síndrome Respiratória do Oriente Médio/crescimento & desenvolvimento , Receptores Virais/metabolismo , Células Vero , Proteínas Virais/metabolismo
3.
J Clin Invest ; 108(1): 83-95, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11435460

RESUMO

Most patients succumbing to colorectal cancer fail with liver-predominant metastases. To make a clinical impact in this disease, a systemic or whole-liver therapy may be required, whereas most cancer gene therapy approaches are limited in their ability to treat beyond local disease. As a preclinical model for cancer gene therapy, recombinant adenovirus containing the human IFN-beta (hIFN-beta) cDNA was delivered systemically in nude mouse xenograft models of human colorectal cancer liver metastases. The vector targeted hepatocytes that produced high levels of hIFN-beta in the liver, resulting in a profound apoptotic response in the tumors and significant tumor regression. hIFN-beta gene therapy not only resulted in improved survival and long-term cure in a micrometastatic model, but provided similar benefits in a clinically relevant gross disease model. A similar recombinant adenovirus containing the murine IFN-beta (mIFN-beta) cDNA also resulted in a therapeutic response and improved survival in syngeneic mouse models of colorectal cancer liver metastases. Depletion studies demonstrate a contribution of natural killer cells to this therapeutic response. The toxicity of an adenoviral vector expressing murine IFN-beta in a syngeneic model is also presented. These encouraging results warrant further investigation of the use of cancer gene therapy for targeting metastatic disease.


Assuntos
Adenocarcinoma/secundário , Adenoviridae/genética , Neoplasias Colorretais/patologia , DNA Complementar/uso terapêutico , Terapia Genética , Vetores Genéticos/uso terapêutico , Interferon beta/uso terapêutico , Neoplasias Hepáticas/secundário , Adenocarcinoma/tratamento farmacológico , Adenocarcinoma/terapia , Animais , Apoptose , Citomegalovirus/genética , DNA Complementar/administração & dosagem , DNA Complementar/genética , DNA Complementar/toxicidade , Feminino , Genes Sintéticos , Vetores Genéticos/administração & dosagem , Vetores Genéticos/genética , Vetores Genéticos/toxicidade , Hepatócitos/metabolismo , Humanos , Injeções Intraperitoneais , Injeções Intravenosas , Interferon beta/administração & dosagem , Interferon beta/genética , Interferon beta/toxicidade , Células Matadoras Naturais/efeitos dos fármacos , Células Matadoras Naturais/imunologia , Neoplasias Hepáticas/tratamento farmacológico , Neoplasias Hepáticas/terapia , Macrófagos/efeitos dos fármacos , Macrófagos/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Nus , Camundongos SCID , Transplante de Neoplasias , Neovascularização Patológica/tratamento farmacológico , Neovascularização Patológica/terapia , Regiões Promotoras Genéticas , Proteínas Recombinantes de Fusão/administração & dosagem , Proteínas Recombinantes de Fusão/fisiologia , Proteínas Recombinantes de Fusão/uso terapêutico , Proteínas Recombinantes de Fusão/toxicidade , Células Tumorais Cultivadas/transplante , Ensaios Antitumorais Modelo de Xenoenxerto
4.
Pharm Acta Helv ; 72(4): 215-23, 1997 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-9372644

RESUMO

The purpose of this study was to elucidate the interaction of cationic liposomes and plasmid cDNA by examining their ultrastructure, zeta potential, stability in aqueous media and protection from DNaseI digestion; their potential for hemolysis and platelet aggregation was evaluated as it may serve as an in vitro toxicity screen. Liposomes consisting of N-[1-(2,3-dioleyloxy)propyl]-N,N,N-trimethylammonium chloride (DOTMA) or 3 beta-[N-(N',N'-dimethylaminoethane)-carbamoyl]-cholesterol (DC-Chol) and dioleylphosphatidylethanolamine (DOPE) were complexed with plasmid constructs of ovine prostaglandin G/H synthase (pCMV4-PGH) or human alpha 1-antitrypsin (pCMV4-AAT) at lipid:plasmid (L/P) ratios of 3:1-8:1 (w/w). The electron micrographs showed bead-like attachment of liposomes to cDNA and coating of plasmid strands. The zeta potential showed isoelectric points at L/P ratios of 3.5-4 (DOTMA/DOPE) and 5.5-6.5, corresponding to a pKa of 6.45 (DC-Chol/DOPE). Liposome cDNA complexes were stable in water, saline and 5% dextrose for 48 h, but precipitated instantaneously in PBS. An increase in the L/P ratio corresponded with increased protection from DNaseI digestion. DOTMA/DOPE liposomes alone were highly hemolytic and DC-Chol/DOPE liposomes moderately hemolytic; hemolysis was abolished by cDNA complexation, with the exception of very high (> or = 7:1) L/P ratios. Both liposomes alone and cDNA complexes caused transient serum turbidity, while none caused platelet aggregation. It was concluded that current cationic lipid cDNA formulations are metastable and appear to have very little if any toxicity with respect to hemolytic potential and untoward interaction with other blood components.


Assuntos
DNA Complementar/administração & dosagem , DNA Complementar/química , DNA Complementar/toxicidade , Desoxirribonucleases/farmacologia , Portadores de Fármacos , Estabilidade de Medicamentos , Terapia Genética , Humanos , Lipossomos , Microscopia Eletrônica , Plasmídeos , Agregação Plaquetária/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...